{
  "id": "normal-pressure-hydrocephalus",
  "title": "Normal Pressure Hydrocephalus",
  "version": "1.1",
  "icd10": [
    "** G91.2 (Normal pressure hydrocephalus)",
    "G91.0 (Communicating hydrocephalus)",
    "R41.0 (Disorientation",
    "unspecified)",
    "R26.0 (Ataxic gait)",
    "R32 (Unspecified urinary incontinence)"
  ],
  "scope": "** Comprehensive evaluation of suspected NPH, diagnostic workup including high-volume lumbar puncture (tap test), prediction of shunt responsiveness, neurosurgical referral, and post-shunt monitoring. Covers idiopathic NPH (most common) and secondary NPH. Does not cover acute obstructive hydrocephalus or pediatric hydrocephalus.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential (85025)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Pre-surgical screening; rule out infection",
          "target": "Normal"
        },
        {
          "item": "BMP (80048)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Electrolyte assessment; pre-surgical renal function",
          "target": "Normal electrolytes, BUN, Cr"
        },
        {
          "item": "Coagulation panel - PT/INR, PTT (85610, 85730)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Pre-procedural assessment for LP and surgery",
          "target": "INR <1.5, PTT <40"
        },
        {
          "item": "TSH (84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hypothyroidism can cause cognitive impairment",
          "target": "0.4-4.0 mIU/L"
        },
        {
          "item": "Vitamin B12 (82607)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "B12 deficiency causes reversible dementia and gait ataxia",
          "target": ">300 pg/mL"
        },
        {
          "item": "Urinalysis with culture (81001, 87086)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Rule out UTI as cause of incontinence or confusion",
          "target": "Negative for infection"
        },
        {
          "item": "Hemoglobin A1c (83036)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Diabetes contributes to small vessel disease and neuropathy",
          "target": "<7%"
        }
      ],
      "Extended Workup (Second-line)": [
        {
          "item": "Folate (82746)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency contributes to cognitive impairment",
          "target": ">3 ng/mL"
        },
        {
          "item": "RPR or VDRL (86592)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Neurosyphilis can cause dementia and gait abnormalities",
          "target": "Nonreactive"
        },
        {
          "item": "HIV antibody (86701)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "HIV-associated neurocognitive disorder in at-risk patients",
          "target": "Negative"
        },
        {
          "item": "ESR, CRP (85652, 86140)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Inflammatory or infectious causes of meningitis/encephalitis",
          "target": "Normal"
        },
        {
          "item": "Hepatic panel (80076)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hepatic encephalopathy in patients with liver disease",
          "target": "Normal"
        },
        {
          "item": "PSA - males (84153)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Prostate disease contributing to urinary symptoms",
          "target": "Normal for age"
        }
      ],
      "Rare/Specialized (Refractory or Atypical)": [
        {
          "item": "Paraneoplastic antibody panel (86255)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Autoimmune etiology if subacute presentation",
          "target": "Negative"
        },
        {
          "item": "Anti-neuronal antibodies - NMDA-R, LGI1, CASPR2 (86235)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Autoimmune encephalitis causing cognitive/behavioral changes",
          "target": "Negative"
        },
        {
          "item": "Genetic testing for APP, PSEN1, PSEN2 (81405)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Early-onset dementia with family history",
          "target": "No pathogenic variants"
        }
      ],
      "Lumbar Puncture": [
        {
          "item": "Opening pressure (62270)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Confirm normal or mildly elevated pressure in NPH",
          "target": "5-18 cm H2O (typically normal or low-normal in NPH)"
        },
        {
          "item": "Cell count - tubes 1 and 4 (89051)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Rule out infection or inflammation",
          "target": "WBC <5, RBC 0"
        },
        {
          "item": "Protein (84157)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Rule out infectious/inflammatory causes",
          "target": "Normal 15-45 mg/dL"
        },
        {
          "item": "Glucose with serum glucose (82947)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Rule out infectious meningitis",
          "target": ">60% of serum glucose"
        },
        {
          "item": "CSF Abeta-42, total tau, p-tau (83519)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Differentiate from Alzheimer's disease (optional)",
          "target": "Normal in NPH; low Abeta-42 with high tau in AD"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "MRI Brain without contrast (70551)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Initial evaluation",
          "target": "Ventriculomegaly with Evans index >0.3; callosal angle <90 degrees; DESH pattern; periventricular edema (transependymal flow); absence of cortical atrophy proportionate to ventricular size",
          "contraindications": "MRI-incompatible devices; claustrophobia"
        },
        {
          "item": "CT Head non-contrast (70450)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If MRI unavailable or emergent presentation",
          "target": "Ventriculomegaly out of proportion to sulcal enlargement; Evans index >0.3",
          "contraindications": "Pregnancy (relative)"
        }
      ],
      "Extended": [
        {
          "item": "MRI Brain with volumetric analysis (70553)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Detailed assessment",
          "target": "Quantify ventricular volume; hippocampal volume preservation (unlike AD); tight high-convexity sulci",
          "contraindications": "MRI contraindications"
        },
        {
          "item": "MRI with CSF flow study - phase-contrast (70553)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Assess aqueductal CSF flow",
          "target": "Hyperdynamic aqueductal flow; increased stroke volume (>42 microL)",
          "contraindications": "MRI contraindications"
        },
        {
          "item": "MR spectroscopy (76390)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Atypical cases to differentiate from AD",
          "target": "Normal NAA/Cr ratio (reduced in AD); no significant metabolic abnormality",
          "contraindications": "MRI contraindications"
        },
        {
          "item": "FDG-PET Brain (78816)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Differentiate NPH from AD or FTD",
          "target": "Preserved metabolism (unlike AD temporoparietal hypometabolism)",
          "contraindications": "None"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Intracranial pressure monitoring - continuous (61210)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "-",
          "timing": "Diagnostic uncertainty after tap test",
          "target": "B-waves present (indicates impaired CSF dynamics)",
          "contraindications": "Coagulopathy; skin infection"
        },
        {
          "item": "Infusion testing - CSF outflow resistance (62270)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Research settings; predict shunt response",
          "target": "Elevated Rout >12-18 mmHg/mL/min suggests shunt responsiveness",
          "contraindications": "Coagulopathy"
        },
        {
          "item": "Radionuclide cisternography (78630)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Rarely used; assesses CSF flow patterns",
          "target": "Delayed clearance over convexities; ventricular reflux",
          "contraindications": "None"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "Acetazolamide",
          "route": "PO",
          "indication": "Temporizing measure while awaiting surgery; reduces CSF production",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mg",
                "orderSentence": "Acetazolamide 250 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 250 mg BID; titrate to 250 mg TID or 500 mg BID; max 2 g/day",
            "orderSentence": "Acetazolamide 250 mg PO"
          },
          "contraindications": "Sulfa allergy; severe hepatic/renal disease; hypokalemia; metabolic acidosis",
          "monitoring": "BMP for potassium, bicarbonate; paresthesias",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Serial therapeutic LP",
          "route": "LP",
          "indication": "Temporizing measure; confirm continued benefit; bridge to surgery",
          "dosing": {
            "doseOptions": [
              {
                "text": "30-50 mL",
                "orderSentence": "Serial therapeutic LP 30-50 mL LP"
              }
            ],
            "route": "LP",
            "instructions": "Remove 30-50 mL every 1-4 weeks based on symptom recurrence",
            "orderSentence": "Serial therapeutic LP 30-50 mL LP"
          },
          "contraindications": "Coagulopathy; anticoagulation; skin infection",
          "monitoring": "Post-LP symptoms; duration of benefit",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptomatic Treatments": [
        {
          "item": "Memantine",
          "route": "PO",
          "indication": "Cognitive symptoms; may provide modest benefit pending surgery",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Memantine 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg daily; increase by 5 mg/week; target 10 mg BID",
            "orderSentence": "Memantine 5 mg PO"
          },
          "contraindications": "Severe renal impairment (adjust dose if CrCl <30)",
          "monitoring": "Confusion, dizziness",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Donepezil",
          "route": "PO",
          "indication": "Cognitive symptoms if AD component suspected",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Donepezil 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg qHS x 4-6 weeks; increase to 10 mg qHS",
            "orderSentence": "Donepezil 5 mg PO"
          },
          "contraindications": "Sick sinus syndrome; GI bleeding; COPD",
          "monitoring": "Bradycardia, GI symptoms",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Oxybutynin",
          "route": "PO",
          "indication": "Urinary urgency/incontinence",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Oxybutynin 5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg BID; may increase to 5 mg TID; or use ER 10-30 mg daily",
            "orderSentence": "Oxybutynin 5 mg PO"
          },
          "contraindications": "Uncontrolled narrow-angle glaucoma; urinary retention; GI obstruction",
          "monitoring": "Anticholinergic effects; cognitive worsening",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Mirabegron",
          "route": "PO",
          "indication": "Urinary urgency if anticholinergics contraindicated or cause cognitive worsening",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg",
                "orderSentence": "Mirabegron 25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25 mg daily; may increase to 50 mg daily",
            "orderSentence": "Mirabegron 25 mg PO"
          },
          "contraindications": "Severe uncontrolled hypertension",
          "monitoring": "Blood pressure",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Tamsulosin",
          "route": "PO",
          "indication": "Urinary retention (males with BPH component)",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 mg",
                "orderSentence": "Tamsulosin 0.4 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 0.4 mg daily; may increase to 0.8 mg daily",
            "orderSentence": "Tamsulosin 0.4 mg PO"
          },
          "contraindications": "Orthostatic hypotension; planned cataract surgery (IFIS)",
          "monitoring": "Orthostatic hypotension",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Trazodone",
          "route": "PO",
          "indication": "Sleep disturbance; sundowning",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg",
                "orderSentence": "Trazodone 25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 25-50 mg qHS; titrate to 50-150 mg qHS",
            "orderSentence": "Trazodone 25 mg PO"
          },
          "contraindications": "Concurrent MAOIs; QT prolongation",
          "monitoring": "Orthostatic hypotension",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy",
          "route": "-",
          "indication": "Gait training and fall prevention",
          "dosing": {
            "doseOptions": [
              {
                "text": "Per PT evaluation",
                "orderSentence": "Physical therapy Per PT evaluation -"
              }
            ],
            "route": "-",
            "instructions": "Initial evaluation plus ongoing therapy for gait training, balance, strength",
            "orderSentence": "Physical therapy Per PT evaluation -"
          },
          "contraindications": "None",
          "monitoring": "Fall risk assessment",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Definitive Treatment (Shunt Surgery)": [
        {
          "item": "Ventriculoperitoneal (VP) shunt",
          "route": "Surgical",
          "indication": "Definitive treatment for NPH; positive tap test or extended drain trial",
          "dosing": {
            "doseOptions": [
              {
                "text": "Programmable valve",
                "orderSentence": "Ventriculoperitoneal (VP) shunt Programmable valve Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Valve pressure setting adjusted based on symptoms; typical starting setting 120-180 mmH2O",
            "orderSentence": "Ventriculoperitoneal (VP) shunt Programmable valve Surgical"
          },
          "contraindications": "Active peritoneal infection; peritoneal adhesions; recent abdominal surgery; ascites",
          "monitoring": "Post-op neuro checks; shunt series imaging; valve setting verification",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ventriculoatrial (VA) shunt",
          "route": "Surgical",
          "indication": "Alternative if peritoneum unsuitable (adhesions, peritonitis history)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Programmable valve",
                "orderSentence": "Ventriculoatrial (VA) shunt Programmable valve Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Catheter tip in right atrium; valve adjusted as VP shunt",
            "orderSentence": "Ventriculoatrial (VA) shunt Programmable valve Surgical"
          },
          "contraindications": "Active bacteremia; severe cardiac disease; pulmonary hypertension",
          "monitoring": "Post-op neuro checks; shunt series imaging; valve setting verification; cardiac monitoring; watch for shunt nephritis",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Lumboperitoneal (LP) shunt",
          "route": "Surgical",
          "indication": "Alternative approach; avoids cranial surgery",
          "dosing": {
            "doseOptions": [
              {
                "text": "Programmable valve",
                "orderSentence": "Lumboperitoneal (LP) shunt Programmable valve Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Catheter from lumbar subarachnoid space to peritoneum",
            "orderSentence": "Lumboperitoneal (LP) shunt Programmable valve Surgical"
          },
          "contraindications": "Spinal stenosis; arachnoiditis; Chiari malformation",
          "monitoring": "Post-op neuro checks; shunt series imaging; valve setting verification; watch for overdrainage with positional changes",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Endoscopic third ventriculostomy (ETV)",
          "route": "Surgical",
          "indication": "Secondary NPH with aqueductal stenosis",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Endoscopic third ventriculostomy (ETV) N/A Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Create opening between third ventricle and interpeduncular cistern",
            "orderSentence": "Endoscopic third ventriculostomy (ETV) N/A Surgical"
          },
          "contraindications": "Communicating hydrocephalus (most iNPH); scarred prepontine cistern",
          "monitoring": "Post-op neuro checks; repeat imaging",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "-"
        }
      ],
      "Post-Shunt Complication Management": [
        {
          "item": "Valve pressure adjustment (overdrainage)",
          "route": "External",
          "indication": "Overdrainage symptoms (headache, subdural hematoma)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Increase setting",
                "orderSentence": "Valve pressure adjustment (overdrainage) Increase setting External programming"
              }
            ],
            "route": "External programming",
            "instructions": "Increase opening pressure by 20-30 mmH2O increments; recheck in 1-2 weeks",
            "orderSentence": "Valve pressure adjustment (overdrainage) Increase setting External programming"
          },
          "contraindications": "None",
          "monitoring": "Symptom response; repeat imaging",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Valve pressure adjustment (underdrainage)",
          "route": "External",
          "indication": "Underdrainage (persistent or worsening NPH symptoms)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Decrease setting",
                "orderSentence": "Valve pressure adjustment (underdrainage) Decrease setting External programming"
              }
            ],
            "route": "External programming",
            "instructions": "Decrease opening pressure by 20-30 mmH2O increments; recheck in 1-2 weeks",
            "orderSentence": "Valve pressure adjustment (underdrainage) Decrease setting External programming"
          },
          "contraindications": "None",
          "monitoring": "Symptom response; repeat imaging",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Vancomycin",
          "route": "IV",
          "indication": "Shunt infection (empiric)",
          "dosing": {
            "doseOptions": [
              {
                "text": "15-20 mg/kg",
                "orderSentence": "Vancomycin 15-20 mg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "15-20 mg/kg IV q8-12h; adjust for renal function; target trough 15-20 mcg/mL",
            "orderSentence": "Vancomycin 15-20 mg/kg IV"
          },
          "contraindications": "Vancomycin allergy",
          "monitoring": "Vancomycin trough; renal function",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Cefepime",
          "route": "IV",
          "indication": "Shunt infection (empiric gram-negative coverage)",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 g",
                "orderSentence": "Cefepime 2 g IV"
              }
            ],
            "route": "IV",
            "instructions": "2 g IV q8h; adjust for renal function",
            "orderSentence": "Cefepime 2 g IV"
          },
          "contraindications": "Cephalosporin allergy",
          "monitoring": "Renal function",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Shunt revision surgery",
          "route": "Surgical",
          "indication": "Shunt malfunction, obstruction, or infection",
          "dosing": {
            "doseOptions": [
              {
                "text": "Per neurosurgery",
                "orderSentence": "Shunt revision surgery Per neurosurgery Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Shunt externalization if infected; revision for mechanical failure",
            "orderSentence": "Shunt revision surgery Per neurosurgery Surgical"
          },
          "contraindications": "Active systemic infection",
          "monitoring": "Post-op monitoring; infection clearance",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology for comprehensive evaluation, differential diagnosis, and coordination of diagnostic workup",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Neurosurgery for shunt candidacy evaluation after positive tap test or extended drain trial",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Neuropsychology for baseline cognitive assessment and differentiation from other dementias (AD, vascular)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy for gait assessment, fall prevention, and baseline measurement for tap test comparison",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Occupational therapy for ADL assessment, home safety evaluation, and cognitive strategies",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Urology for evaluation if urinary symptoms prominent or atypical for NPH",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Social work for caregiver support, community resources, and care planning",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Geriatrics or geriatric psychiatry for complex older patients with multiple comorbidities",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Patient Instructions": [
        {
          "item": "Return immediately if sudden severe headache, new weakness, or altered consciousness develops (may indicate shunt malfunction or complication)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report fever, incision redness, or drainage after shunt surgery (may indicate shunt infection)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "Keep scheduled follow-up appointments for shunt valve pressure adjustments and monitoring",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Use assistive devices (walker, cane) as recommended by physical therapy to prevent falls",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do not drive until cleared by physician due to cognitive impairment and fall risk",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid MRI without confirming shunt valve is MRI-conditional and checking valve setting afterward",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Carry shunt information card with valve type and current pressure setting",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Fall precautions including removal of throw rugs, adequate lighting, grab bars in bathroom due to gait instability",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Regular physical activity within safe limits to maintain strength and mobility",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Cognitive stimulation through reading, puzzles, and social engagement to support cognitive reserve",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "Blood pressure optimization (target <130/80) to reduce vascular contribution to cognitive impairment",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Adequate hydration to maintain optimal CSF dynamics; avoid dehydration",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Bladder training program in conjunction with physical therapy for urinary symptoms",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Alzheimer's disease",
      "features": "Memory impairment predominant; insidious progression; no significant gait disturbance early; no improvement with LP",
      "tests": "MRI shows hippocampal atrophy >ventricular enlargement; CSF low Abeta-42, high tau; no tap test response"
    },
    {
      "diagnosis": "Vascular dementia",
      "features": "Stepwise decline; focal neurological signs; executive dysfunction; vascular risk factors",
      "tests": "MRI shows extensive white matter disease, strategic infarcts; ventriculomegaly less prominent"
    },
    {
      "diagnosis": "Parkinson's disease",
      "features": "Rest tremor; rigidity; bradykinesia; shuffling gait differs from NPH magnetic gait; no incontinence early",
      "tests": "DaTscan abnormal; no tap test response; no ventriculomegaly disproportionate to atrophy"
    },
    {
      "diagnosis": "Dementia with Lewy bodies",
      "features": "Visual hallucinations; fluctuating cognition; parkinsonism; REM sleep behavior disorder",
      "tests": "DaTscan abnormal; no ventricular enlargement out of proportion to atrophy"
    },
    {
      "diagnosis": "Progressive supranuclear palsy",
      "features": "Vertical gaze palsy; postural instability with falls backward; axial rigidity",
      "tests": "MRI midbrain atrophy (\"hummingbird sign\"); no tap test response"
    },
    {
      "diagnosis": "Cervical spondylotic myelopathy",
      "features": "Upper motor neuron signs in legs; hyperreflexia; Babinski; sensory level",
      "tests": "Cervical MRI shows cord compression; EMG findings"
    },
    {
      "diagnosis": "Peripheral neuropathy",
      "features": "Sensory loss distally; reduced reflexes; no cognitive or urinary symptoms",
      "tests": "EMG/NCS confirms peripheral nerve involvement"
    },
    {
      "diagnosis": "Obstructive hydrocephalus",
      "features": "Acute onset; headache; papilledema; elevated opening pressure on LP",
      "tests": "MRI shows obstructive lesion; elevated ICP; requires emergent intervention"
    },
    {
      "diagnosis": "Spinal stenosis",
      "features": "Neurogenic claudication; leg pain with walking relieved by rest/leaning forward",
      "tests": "Lumbar MRI shows stenosis; normal brain imaging"
    },
    {
      "diagnosis": "Frontotemporal dementia",
      "features": "Behavioral changes prominent; personality changes; language impairment",
      "tests": "MRI frontal/temporal atrophy; FDG-PET frontal hypometabolism"
    }
  ],
  "evidence": [
    {
      "recommendation": "Evans index >0.3 diagnostic for ventriculomegaly",
      "evidenceLevel": "Class II, Level B",
      "source": "[Relkin et al. Neurosurgery 2005 (iNPH Guidelines)](https://pubmed.ncbi.nlm.nih.gov/16160425/)"
    },
    {
      "recommendation": "Callosal angle <90 degrees supports iNPH diagnosis",
      "evidenceLevel": "Class III, Level C",
      "source": "[Virhammar et al. J Neurosurg 2014](https://pubmed.ncbi.nlm.nih.gov/24074491/)"
    },
    {
      "recommendation": "DESH (disproportionately enlarged subarachnoid-space hydrocephalus) pattern",
      "evidenceLevel": "Class II, Level B",
      "source": "[Hashimoto et al. AJNR 2010](https://pubmed.ncbi.nlm.nih.gov/21921530/)"
    },
    {
      "recommendation": "High-volume LP (tap test) predicts shunt response",
      "evidenceLevel": "Class II, Level B",
      "source": "[Marmarou et al. J Neurosurg 2005](https://pubmed.ncbi.nlm.nih.gov/16028756/)"
    },
    {
      "recommendation": "Extended lumbar drainage more sensitive than single tap test",
      "evidenceLevel": "Class II, Level B",
      "source": "[Walchenbach et al. J Neurol Neurosurg Psychiatry 2002](https://pubmed.ncbi.nlm.nih.gov/11909911/)"
    },
    {
      "recommendation": "VP shunt improves symptoms in selected iNPH patients",
      "evidenceLevel": "Class II, Level B",
      "source": "[Hebb et al. Can J Neurol Sci 2001](https://pubmed.ncbi.nlm.nih.gov/11846911/)"
    },
    {
      "recommendation": "Programmable valves reduce revision surgery rates",
      "evidenceLevel": "Class II, Level B",
      "source": "[Zemack et al. Eur J Neurol 2003](https://pubmed.ncbi.nlm.nih.gov/12650416/)"
    },
    {
      "recommendation": "Gait improvement most responsive to shunting",
      "evidenceLevel": "Class II, Level B",
      "source": "[Mori et al. Neurol Med Chir 2012](https://pubmed.ncbi.nlm.nih.gov/23183074/)"
    },
    {
      "recommendation": "Short symptom duration predicts better shunt outcome",
      "evidenceLevel": "Class II, Level B",
      "source": "[Relkin et al. Neurosurgery 2005](https://pubmed.ncbi.nlm.nih.gov/16160425/)"
    },
    {
      "recommendation": "CSF biomarkers help differentiate NPH from AD",
      "evidenceLevel": "Class III, Level C",
      "source": "[Tarnaris et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21411220/)"
    },
    {
      "recommendation": "Shunt infection rate 5-10%; requires shunt removal for treatment",
      "evidenceLevel": "Class III, Level C",
      "source": "[McGirt et al. J Neurosurg 2003](https://pubmed.ncbi.nlm.nih.gov/12816268/)"
    },
    {
      "recommendation": "Japanese iNPH Guidelines diagnostic criteria",
      "evidenceLevel": "Class II, Level B",
      "source": "[Mori et al. Neurol Med Chir 2012](https://pubmed.ncbi.nlm.nih.gov/23037929/)"
    }
  ],
  "monitoring": [
    {
      "item": "Gait assessment (timed 10m walk, Tinetti)",
      "frequency": "Pre-LP, post-LP, each follow-up",
      "action": "Positive change supports diagnosis; no change may indicate poor shunt candidacy",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "MoCA or MMSE",
      "frequency": "Baseline, post-LP, every 6 months",
      "action": "Improvement suggests NPH; decline suggests alternative diagnosis or shunt failure",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Post-shunt imaging (CT or MRI)",
      "frequency": "1-2 days post-op, 3 months, then PRN",
      "action": "Repeat imaging if symptoms change; adjust valve",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Shunt valve setting verification",
      "frequency": "After any MRI; at each clinic visit",
      "action": "Reprogram if reset; ensure appropriate setting",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Neurological exam",
      "frequency": "Each clinic visit",
      "action": "Decline triggers workup for shunt malfunction or alternative diagnosis",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Subdural hematoma surveillance",
      "frequency": "Post-shunt, especially if headache",
      "action": "Adjust valve pressure higher; surgical evacuation if large/symptomatic",
      "ED": "STAT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Signs of shunt infection",
      "frequency": "Post-operatively and ongoing",
      "action": "Blood/CSF cultures; shunt tap; IV antibiotics; possible shunt removal",
      "ED": "STAT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Urinary symptom diary",
      "frequency": "Baseline and follow-up",
      "action": "Adjust bladder medications; confirm NPH response",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "ADL/IADL function",
      "frequency": "Every 6 months",
      "action": "Increase support services; OT reassessment",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    }
  ],
  "disposition": [
    {
      "disposition": "Discharge home",
      "criteria": "Stable symptoms; workup complete; awaiting outpatient tap test; caregiver support available"
    },
    {
      "disposition": "Admit to floor",
      "criteria": "Extended lumbar drain trial; post-shunt observation; shunt complication evaluation"
    },
    {
      "disposition": "Admit to ICU",
      "criteria": "Acute shunt malfunction with altered mental status; symptomatic overdrainage with large subdural; shunt infection with sepsis"
    },
    {
      "disposition": "Outpatient follow-up",
      "criteria": "Neurology 2-4 weeks after tap test to review results; Neurosurgery evaluation if positive tap test; post-shunt follow-up at 1-3 months, 6 months, then annually"
    },
    {
      "disposition": "Urgent neurosurgery referral",
      "criteria": "Positive tap test; positive extended drain trial; progressive symptoms with classic imaging findings"
    }
  ]
}